LEE NANCY M has a total of 17 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CELERA CORP, WAYNE JOHN CANCER INST and DAIRY CATTLE RES CENTER OF SHANDONG ACADEMY OF AGRICULTURAL SCIENCES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Australia | 1 | |
#6 | Czechia | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Computer technology | |
#6 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Peptides | |
#5 | Diagnosis and surgery | |
#6 | Analysing materials | |
#7 | Animal care | |
#8 | Microorganisms | |
#9 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Lee Nancy M | 17 |
#2 | Loh Horace H | 6 |
#3 | Goldstein Avram | 4 |
#4 | Roy Sabita | 4 |
#5 | Ramakrishnan S | 4 |
#6 | Chen Ling C | 2 |
#7 | Lippman David | 1 |
#8 | Lee Peter L | 1 |
#9 | Takemori Akira E | 1 |
Publication | Filing date | Title |
---|---|---|
US2010261221A1 | Method to predict or diagnose a gastrointestinal disorder or disease | |
US2006088862A1 | Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof | |
CZ52397A3 | Analgesic method by dynorphin analogs being modified at n-end | |
CA2198348A1 | Analgesic method with dynorphin analogues truncated at the n-terminus | |
WO9325217A1 | Des-tyr dynorphin analogues | |
WO9321309A1 | Oligonucleotide sequences and transgenic animals transfected therewith having reduced sensitivity to narcotic analgesics | |
EP0541694A1 | Method for treating immune system dysfunctions |